Sight Sciences, Inc.
SGHT
$5.51
$0.010.18%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 79.55M | 77.36M | 76.05M | 76.30M | 78.11M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 79.55M | 77.36M | 76.05M | 76.30M | 78.11M |
| Cost of Revenue | 11.00M | 10.70M | 10.61M | 11.15M | 11.20M |
| Gross Profit | 68.55M | 66.67M | 65.44M | 65.15M | 66.91M |
| SG&A Expenses | 84.28M | 87.36M | 92.54M | 95.98M | 98.79M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 107.01M | 111.66M | 118.61M | 124.99M | 127.78M |
| Operating Income | -27.45M | -34.30M | -42.56M | -48.68M | -49.67M |
| Income Before Tax | -37.27M | -38.42M | -46.07M | -48.72M | -49.14M |
| Income Tax Expenses | -20.00K | 10.00K | 40.00K | 285.00K | 260.00K |
| Earnings from Continuing Operations | -37.25 | -38.43 | -46.11 | -49.01 | -49.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -37.25M | -38.43M | -46.11M | -49.01M | -49.40M |
| EBIT | -27.45M | -34.30M | -42.56M | -48.68M | -49.67M |
| EBITDA | -27.01M | -33.81M | -42.01M | -48.08M | -49.00M |
| EPS Basic | -0.71 | -0.74 | -0.90 | -0.96 | -0.98 |
| Normalized Basic EPS | -0.35 | -0.43 | -0.53 | -0.60 | -0.61 |
| EPS Diluted | -0.71 | -0.74 | -0.90 | -0.96 | -0.98 |
| Normalized Diluted EPS | -0.35 | -0.43 | -0.53 | -0.60 | -0.61 |
| Average Basic Shares Outstanding | 211.22M | 208.57M | 206.29M | 204.25M | 202.33M |
| Average Diluted Shares Outstanding | 211.22M | 208.57M | 206.29M | 204.25M | 202.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |